Investor

Novo Holdings A/S

Last cheque observed Mar 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

QuietGrowth equity

Series ASeries BSeries C

Cheques on record
0%of best year0cheques in 12 months, 93 on record
Since the last cheque609days00hrs00min00sec
Median round$40MRounds led4 of 93Sole investor9 roundsExits12 from the portfolioMostly inUnited States, 64%
Pitch Novo Holdings A/S

Novo Holdings A/S highlights

  1. 01

    93 rounds on record

  2. 02

    Mostly Series A and Series B: 51% of its rounds

  3. 03

    Sole investor in 9 rounds, median $31M

  4. 04

    12 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first93 appearances

  1. 2025

    2 rounds

  2. Mar
    Hillstar BioSeries A · US · Firms' own news pages$67MWith 5 others
  3. Jan
    Coave TherapeuticsSeries A · FR · Seroba Life Sciences$33MLed
  4. 2019

    3 rounds

  5. Oct
    Disc MedicineSeries A · US · FinSMEs$50MLed
  6. Aug
    GlycomineSeries B · US · FinSMEs$33MLed
  7. Jun
    VestaronSeries B · US · FinSMEs$40MLed
  8. 2018

    3 rounds

  9. Dec
    Aristea TherapeuticsSeries A · US · FinSMEs$15MSole investor
  10. Nov
    Mirum TherapeuticsSeries A · US · FinSMEs$120MWith 5 others
  11. Oct
    RgenixSeries C · US · FinSMEs$40MWith 4 others
  12. 2017

    1 round

  13. Nov
    Outpost MedicineSeries A · GB · FinSMEs$20MWith 5 others
  14. 2015

    6 rounds

  15. Oct
    SymphogenDebt · DK$77MWith 1 other
  16. Jul
    KalVista PharmaceuticalsSeries B · GB$33MWith 4 others
  17. Jul
    Procept BioRoboticsUS$42MWith 1 other
  18. Jun
    UNUM TherapeuticsSeries B · US$65MWith 11 others
  19. May
    BiosyntiaSeed · DK$1.9MWith 1 other
  20. Apr
    MerusSeries C · NL$79MWith 10 others
  21. 2014

    9 rounds

  22. Sept
    AdaptimmuneSeries A · GB$104MWith 12 others
  23. Sept
    PulmologixVenture$12MWith 2 others
  24. May
    Tarsa TherapeuticsSeries B · US$7.0MWith 3 others
  25. May
    iRhythm TechnologiesSeries E · US$17MWith 1 other
  26. Apr
    SI-BONEVenture · US$33MWith 3 others
  27. Apr
    Nora TherapeuticsSeries B · US$18MWith 4 others
  28. Apr
    Spinifex PharmaceuticalsSeries C · GB$45MWith 4 others
  29. Mar
    ZS PharmaSeries D · US$55MWith 8 others
  30. Jan
    OphthotechUS$42MSole investor
  31. 2013

    9 rounds

  32. Nov
    Delenex TherapeuticsSeries A · CH · startupticker.ch$8.0MWith 4 others
  33. Sept
    Acacia PharmaSeries B · GB · finsmes.com$24MWith 2 others
  34. Aug
    ObsEvaSeries A · CH · marketwatch.com$33MWith 1 other
  35. Jun
    Akebia TherapeuticsSeries C · US · finsmes.com$41MWith 8 others
  36. May
    OphthotechSeries C · US · pehub.com$50MSole investor
  37. May
    OphthotechGrowth · US$50MSole investor
  38. May
    OphthotechGrowth · US · pehub.com$125MSole investor
  39. May
    SymphogenGrowth · DK · finsmes.com$54MWith 2 others
  40. Mar
    PTC TherapeuticsGrowth · US · finsmes.com$60MWith 8 others
  41. 2012

    7 rounds

  42. Sept
    Karus TherapeuticsSeries B · GB · pevc.dowjones.com$7.6MWith 3 others
  43. Jul
    PTC TherapeuticsGrowth · US · finsmes.com$30MWith 4 others
  44. Jun
    Santaris PharmaVenture · DK · pevc.dowjones.com$12MWith 5 others
  45. Apr
    InogenVenture · US · inogenone.com$20MSole investor
  46. Apr
    AlloCureSeries B · US · masshightech.com$25MWith 2 others
  47. Mar
    Tarsa TherapeuticsSeries B · US · prnewswire.com$28MWith 4 others
  48. Feb
    AltheosSeries A · US · fiercebiotech.com$13MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed12 in all

ZS PharmaBought by AstraZeneca$2.7BNov 2015
Spinifex PharmaceuticalsBought by Novartis$200MJun 2015
Santaris PharmaBought by Roche$450MAug 2014
Archimedes PharmaBought by ProStrakanUndisclosedJul 2014
CellBiosciencesBought by Bio-TechneUndisclosedJun 2014
PTC TherapeuticsListed$125MJun 2013
CytochromaBought by OPKO HealthUndisclosedJan 2013
Amira PharmaceuticalsBought by Bristol-Myers Squibb$325MJul 2011
Synosia TherapeuticsBought by Biotie Therapies$122MJan 2011
Protein ForestBought by CellBiosciencesUndisclosedDec 2009
InogenListed$86MDec 2008
Corus PharmaBought by Gilead SciencesUndisclosedOct 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Novo Holdings A/S. A count of rooms they were both in, not a relationship either has claimed.

SV Life SciencesVC firm12rounds togetherHBM BioVenturesGrowth equity10rounds togetherBay City CapitalVC firm8rounds togetherDelphi VenturesVC firm8rounds togetherCredit SuisseVC firm6rounds togetherEssex Woodlands Healthcare PartnersVC firm5rounds togetherMVM Life Science PartnersVC firm5rounds togetherVersant VenturesVC firm5rounds togetherBurrill & CompanyVC firm4rounds togetherCanaanVC firm4rounds togetherNovo HoldingsVC firm4rounds togetherOrbiMedPrivate equity4rounds together

Recently backed

The latest companies Novo Holdings A/S put money into.

Hillstar Bio$67M · Mar 2025Coave Therapeutics$33M · Jan 2025Disc Medicine$50M · Oct 2019Glycomine$33M · Aug 2019Outpost Medicine$20M · Nov 2017

Quick answers about Novo Holdings A/S

What does Novo Holdings A/S invest in?

Novo Holdings A/S invests most often at Series A and Series B (51% of the rounds on record).

How active is Novo Holdings A/S?

93 investments on record, 0 of them in the last 12 months, and it led 4. The most recent was in Mar 2025.

What has Novo Holdings A/S invested in recently?

Its most recent investments on record: Hillstar Bio (Series A, Mar 2025), Coave Therapeutics (Series A, Jan 2025) and Disc Medicine (Series A, Oct 2019).

How big are Novo Holdings A/S's cheques?

The median round it joins is $40M.

Does Novo Holdings A/S lead rounds?

Sometimes: it led 4 of its 93 investments on record (4%).

Where does Novo Holdings A/S invest?

Most of the companies it backs are in the United States (64%), the United Kingdom (15%) and Denmark (10%).

Is Novo Holdings A/S investing now?

No investments in the last 12 months; the latest was in Mar 2025.

Who does Novo Holdings A/S invest alongside?

Most often SV Life Sciences (12 rounds together), HBM BioVentures (10 rounds together) and Bay City Capital (8 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it